Baseline corrected and/ or uncorrected Ursodiol [Regulatives / Guidelines]

posted by cr.maroj – UK, 2013-12-19 17:42 (4567 d 20:06 ago) – Posting: # 12080
Views: 5,286

Dear forum members,

For Ursodiol capsules FDA recommends:

Bioequivalence based on (90% CI): Baseline corrected and uncorrected (i) unconjugated ursodiol and (ii) total (conjugated and unconjugated) ursodiol.

However we intend to submit to MHRA. Could someone please advise if MHRA also insists on baseline corrected as well as uncorrected data, or only baseline corrected data will be sufficient to show BE.

Thank you,
Kind regards,
CR

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
130 visitors (0 registered, 130 guests [including 20 identified bots]).
Forum time: 14:48 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5